Inventor
WALKER LAURA MARJORIE
US10 patents
⚠️ This page may combine multiple inventors who share the name “WALKER LAURA MARJORIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERACLONE SCIENCES INC
9 patentsUS9464131B2Oct 11, 2016
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC18 citations91
US11319362B2May 3, 2022
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC3 citations83
US10865234B2Dec 15, 2020
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US10407493B2Sep 10, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US12312396B2May 27, 2025
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US12018067B2Jun 25, 2024
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11584789B2Feb 21, 2023
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US10239934B2Mar 26, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
US9920111B2Mar 20, 2018
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51